Die Umsetzung der Global Compact-Prinzipien: in Pharmaunternehmen
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis Book |
| Language: | German |
| Published: |
2006
|
| Subjects: | |
| Physical Description: | 66 S. |
Staff View
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV026927972 | ||
| 003 | DE-604 | ||
| 005 | 20110228 | ||
| 007 | t | ||
| 008 | 110326s2006 m||| 00||| ger d | ||
| 035 | |a (OCoLC)918181247 | ||
| 035 | |a (DE-599)BVBBV026927972 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a ger | |
| 049 | |a DE-188 | ||
| 100 | 1 | |a Lober, Nathalie |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Die Umsetzung der Global Compact-Prinzipien |b in Pharmaunternehmen |c Nathalie Lober |
| 264 | 1 | |c 2006 | |
| 300 | |a 66 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 502 | |a Berlin, Freie Univ., Masterarbeit, 2006 | ||
| 610 | 2 | 7 | |a Bayer Schering Pharma AG |0 (DE-588)10157603-1 |2 gnd |9 rswk-swf |
| 610 | 2 | 7 | |a Global Compact |0 (DE-588)4702032-5 |2 gnd |9 rswk-swf |
| 610 | 2 | 7 | |a Novartis AG |0 (DE-588)2163228-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Globalisierung |0 (DE-588)4557997-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Corporate Social Responsibility |0 (DE-588)7697760-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Public Private Partnership |0 (DE-588)4337462-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Unternehmensethik |0 (DE-588)4202404-3 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Global Compact |0 (DE-588)4702032-5 |D b |
| 689 | 0 | 1 | |a Public Private Partnership |0 (DE-588)4337462-1 |D s |
| 689 | 0 | 2 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |D s |
| 689 | 0 | 3 | |a Globalisierung |0 (DE-588)4557997-0 |D s |
| 689 | 0 | 4 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | |5 DE-188 | |
| 689 | 1 | 0 | |a Novartis AG |0 (DE-588)2163228-5 |D b |
| 689 | 1 | 1 | |a Bayer Schering Pharma AG |0 (DE-588)10157603-1 |D b |
| 689 | 1 | 2 | |a Global Compact |0 (DE-588)4702032-5 |D b |
| 689 | 1 | 3 | |a Unternehmensethik |0 (DE-588)4202404-3 |D s |
| 689 | 1 | 4 | |a Corporate Social Responsibility |0 (DE-588)7697760-2 |D s |
| 689 | 1 | |5 DE-188 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-022450657 | ||
Record in the Search Index
| _version_ | 1804145566709448704 |
|---|---|
| any_adam_object | |
| author | Lober, Nathalie |
| author_facet | Lober, Nathalie |
| author_role | aut |
| author_sort | Lober, Nathalie |
| author_variant | n l nl |
| building | Verbundindex |
| bvnumber | BV026927972 |
| ctrlnum | (OCoLC)918181247 (DE-599)BVBBV026927972 |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02044nam a2200517 c 4500</leader><controlfield tag="001">BV026927972</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20110228 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">110326s2006 m||| 00||| ger d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)918181247</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV026927972</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-188</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lober, Nathalie</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Die Umsetzung der Global Compact-Prinzipien</subfield><subfield code="b">in Pharmaunternehmen</subfield><subfield code="c">Nathalie Lober</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">66 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="a">Berlin, Freie Univ., Masterarbeit, 2006</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Bayer Schering Pharma AG</subfield><subfield code="0">(DE-588)10157603-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Global Compact</subfield><subfield code="0">(DE-588)4702032-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Novartis AG</subfield><subfield code="0">(DE-588)2163228-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Globalisierung</subfield><subfield code="0">(DE-588)4557997-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Corporate Social Responsibility</subfield><subfield code="0">(DE-588)7697760-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Public Private Partnership</subfield><subfield code="0">(DE-588)4337462-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Unternehmensethik</subfield><subfield code="0">(DE-588)4202404-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Global Compact</subfield><subfield code="0">(DE-588)4702032-5</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Public Private Partnership</subfield><subfield code="0">(DE-588)4337462-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Globalisierung</subfield><subfield code="0">(DE-588)4557997-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-188</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Novartis AG</subfield><subfield code="0">(DE-588)2163228-5</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Bayer Schering Pharma AG</subfield><subfield code="0">(DE-588)10157603-1</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Global Compact</subfield><subfield code="0">(DE-588)4702032-5</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Unternehmensethik</subfield><subfield code="0">(DE-588)4202404-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="4"><subfield code="a">Corporate Social Responsibility</subfield><subfield code="0">(DE-588)7697760-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-188</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-022450657</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV026927972 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T23:21:29Z |
| institution | BVB |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-022450657 |
| oclc_num | 918181247 |
| open_access_boolean | |
| owner | DE-188 |
| owner_facet | DE-188 |
| physical | 66 S. |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| record_format | marc |
| spelling | Lober, Nathalie Verfasser aut Die Umsetzung der Global Compact-Prinzipien in Pharmaunternehmen Nathalie Lober 2006 66 S. txt rdacontent n rdamedia nc rdacarrier Berlin, Freie Univ., Masterarbeit, 2006 Bayer Schering Pharma AG (DE-588)10157603-1 gnd rswk-swf Global Compact (DE-588)4702032-5 gnd rswk-swf Novartis AG (DE-588)2163228-5 gnd rswk-swf Globalisierung (DE-588)4557997-0 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Gesundheitspolitik (DE-588)4113743-7 gnd rswk-swf Corporate Social Responsibility (DE-588)7697760-2 gnd rswk-swf Public Private Partnership (DE-588)4337462-1 gnd rswk-swf Unternehmensethik (DE-588)4202404-3 gnd rswk-swf (DE-588)4113937-9 Hochschulschrift gnd-content Global Compact (DE-588)4702032-5 b Public Private Partnership (DE-588)4337462-1 s Gesundheitspolitik (DE-588)4113743-7 s Globalisierung (DE-588)4557997-0 s Pharmazeutische Industrie (DE-588)4045696-1 s DE-188 Novartis AG (DE-588)2163228-5 b Bayer Schering Pharma AG (DE-588)10157603-1 b Unternehmensethik (DE-588)4202404-3 s Corporate Social Responsibility (DE-588)7697760-2 s |
| spellingShingle | Lober, Nathalie Die Umsetzung der Global Compact-Prinzipien in Pharmaunternehmen Bayer Schering Pharma AG (DE-588)10157603-1 gnd Global Compact (DE-588)4702032-5 gnd Novartis AG (DE-588)2163228-5 gnd Globalisierung (DE-588)4557997-0 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Corporate Social Responsibility (DE-588)7697760-2 gnd Public Private Partnership (DE-588)4337462-1 gnd Unternehmensethik (DE-588)4202404-3 gnd |
| subject_GND | (DE-588)10157603-1 (DE-588)4702032-5 (DE-588)2163228-5 (DE-588)4557997-0 (DE-588)4045696-1 (DE-588)4113743-7 (DE-588)7697760-2 (DE-588)4337462-1 (DE-588)4202404-3 (DE-588)4113937-9 |
| title | Die Umsetzung der Global Compact-Prinzipien in Pharmaunternehmen |
| title_auth | Die Umsetzung der Global Compact-Prinzipien in Pharmaunternehmen |
| title_exact_search | Die Umsetzung der Global Compact-Prinzipien in Pharmaunternehmen |
| title_full | Die Umsetzung der Global Compact-Prinzipien in Pharmaunternehmen Nathalie Lober |
| title_fullStr | Die Umsetzung der Global Compact-Prinzipien in Pharmaunternehmen Nathalie Lober |
| title_full_unstemmed | Die Umsetzung der Global Compact-Prinzipien in Pharmaunternehmen Nathalie Lober |
| title_short | Die Umsetzung der Global Compact-Prinzipien |
| title_sort | die umsetzung der global compact prinzipien in pharmaunternehmen |
| title_sub | in Pharmaunternehmen |
| topic | Bayer Schering Pharma AG (DE-588)10157603-1 gnd Global Compact (DE-588)4702032-5 gnd Novartis AG (DE-588)2163228-5 gnd Globalisierung (DE-588)4557997-0 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Corporate Social Responsibility (DE-588)7697760-2 gnd Public Private Partnership (DE-588)4337462-1 gnd Unternehmensethik (DE-588)4202404-3 gnd |
| topic_facet | Bayer Schering Pharma AG Global Compact Novartis AG Globalisierung Pharmazeutische Industrie Gesundheitspolitik Corporate Social Responsibility Public Private Partnership Unternehmensethik Hochschulschrift |
| work_keys_str_mv | AT lobernathalie dieumsetzungderglobalcompactprinzipieninpharmaunternehmen |